Colonic epithelial cell activation and the paradoxical effects of butyrate

被引:76
作者
Gibson, PR [1 ]
Rosella, O
Wilson, AJ
Mariadason, JM
Rickard, K
Byron, K
Barkla, DH
机构
[1] Univ Melbourne, Dept Med, Parkville, Vic 3050, Australia
[2] Monash Univ, Dept Anat, Clayton, Vic 3168, Australia
关键词
D O I
10.1093/carcin/20.4.539
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Butyrate may have paradoxical effects on epithelial cells of similar origin. This study aimed to examine the hypothesis that one mechanism that dictates a cell's response to butyrate is its state of activation. First, the responses to 24 h exposure to butyrate (1-2 mM) of normal and neoplastic human colonic epithelial cells activated by their isolation and primary culture, and of colon cancer cell lines, LLM1215 and Caco-2, were examined, In primary cultures of normal and cancer cells, butyrate had no effect on alkaline phosphatase activities but significantly suppressed urokinase receptor expression by a mean +/- SEM of 30 +/- 12% and 36 +/- 9%, respectively, Interleukin-8 secretion was suppressed by 44 +/- 7% in normal cells (P < 0.05) but was unchanged in cancer cells. In contrast, the cell lines significantly increased alkaline phosphatase activities by >50%, urokinase receptor expression >2-fold and interleukin-8 secretion >3-fold in response to butyrate, Secondly, the effect of butyrate on Caco-2 cells was examined with or without prior exposure to a specific activating stimulus [tumour necrosis factor alpha (TNF alpha)]. Interleukin-8 secretion increased by 145 +/- 23% and 132 +/- 17% on 24 h exposure to 2 mM butyrate or 0.1 mu M TNF alpha alone, respectively. However, in cells pre-treated with TNF alpha, butyrate significantly inhibited secretion by 34 +/- 7% below unstimulated levels. The response to butyrate of urokinase receptor, whose expression was not stimulated by TNF alpha, was unchanged. These effects were mimicked by trichostatin A, an inhibitor of histone deacetylase, suggesting that butyrate's paradoxical effects may have been operating by the same mechanism. In conclusion, some of the paradoxical effects of butyrate do not appear to represent inherent differences between normal and transformed cells. Rather, the response may be determined by the state of activation of the cells.
引用
收藏
页码:539 / 544
页数:6
相关论文
共 41 条
[1]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[2]  
2-Z
[3]   Butyrate inhibits colon carcinoma cell growth through two distinct pathways [J].
Archer, S ;
Meng, SF ;
Wu, J ;
Johnson, J ;
Tang, R ;
Hodin, R .
SURGERY, 1998, 124 (02) :248-253
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   ON THE BIOLOGICAL ROLE OF HISTONE ACETYLATION [J].
CSORDAS, A .
BIOCHEMICAL JOURNAL, 1990, 265 (01) :23-38
[6]   SHORT CHAIN FATTY-ACIDS IN THE HUMAN-COLON [J].
CUMMINGS, JH .
GUT, 1981, 22 (09) :763-779
[7]   SODIUM-BUTYRATE INHIBITS EXPRESSION OF UROKINASE AND ITS RECEPTOR MESSENGER-RNAS AT BOTH TRANSCRIPTION AND POST-TRANSCRIPTION LEVELS IN COLON-CANCER CELLS [J].
DANG, JJ ;
WANG, Y ;
DOE, WF .
FEBS LETTERS, 1995, 359 (2-3) :147-150
[8]   Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model [J].
DArgenio, G ;
Cosenza, V ;
DelleCave, M ;
Iovino, P ;
DellaValle, N ;
Lombardi, G ;
Mazzacca, G .
GASTROENTEROLOGY, 1996, 110 (06) :1727-1734
[9]   UROKINASE RECEPTOR AND COLORECTAL-CANCER SURVIVAL [J].
GANESH, S ;
SIER, CFM ;
HEERDING, MM ;
GRIFFIOEN, G ;
LAMERS, CBHW ;
VERSPAGET, HW .
LANCET, 1994, 344 (8919) :401-402
[10]   INTERLEUKIN-8 SECRETION BY COLONIC CRYPT CELLS IN-VITRO - RESPONSE TO INJURY SUPPRESSED BY BUTYRATE AND ENHANCED IN INFLAMMATORY BOWEL-DISEASE [J].
GIBSON, P ;
ROSELLA, O .
GUT, 1995, 37 (04) :536-543